| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.042 | 0.3 |